Supportive Care in Cancer

, Volume 22, Issue 1, pp 3–6

Caphosol, a therapeutic option in case of cancer therapy-induced oral mucositis in children?

Results from a prospective multicenter double blind randomized controlled trial
  • M. F. Raphael
  • A. M. den Boer
  • W. J. W. Kollen
  • H. Mekelenkamp
  • F. C. H. Abbink
  • G. J. L. Kaspers
  • K. Zomer-Kooijker
  • B. H. W. Molmans
  • W. J. E. Tissing
Letter to the editor

DOI: 10.1007/s00520-013-2015-0

Cite this article as:
Raphael, M.F., den Boer, A.M., Kollen, W.J.W. et al. Support Care Cancer (2014) 22: 3. doi:10.1007/s00520-013-2015-0

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • M. F. Raphael
    • 1
  • A. M. den Boer
    • 1
  • W. J. W. Kollen
    • 2
  • H. Mekelenkamp
    • 2
  • F. C. H. Abbink
    • 3
  • G. J. L. Kaspers
    • 3
  • K. Zomer-Kooijker
    • 4
  • B. H. W. Molmans
    • 5
  • W. J. E. Tissing
    • 6
  1. 1.Department of Pediatric Hematology and Oncology, Wilhelmina Children’s HospitalUniversity Medical Center UtrechtUtrechtThe Netherlands
  2. 2.Department of Pediatric Hematology and OncologyLeiden University Medical CenterLeidenThe Netherlands
  3. 3.Department of Pediatric Hematology and OncologyVU University Medical CenterAmsterdamThe Netherlands
  4. 4.Department of Pediatrics, Wilhelmina Children’s HospitalUniversity Medical Center UtrechtUtrechtThe Netherlands
  5. 5.Department of Hospital and Clinical Pharmacy, Beatrix Children’s Hospital, University Medical Center GroningenUniversity of GroningenGroningenThe Netherlands
  6. 6.Department of Pediatric Hematology and Oncology, Beatrix Children’s Hospital, University Medical Center GroningenUniversity of GroningenGroningenThe Netherlands

Personalised recommendations